What is Atea Pharmaceuticals, Inc. Common Stock's Market Cap?

Atea Pharmaceuticals, Inc. Common Stock's Market Cap is $455.6M, based on as-reported figures from SEC (XBRL) filings.

What is Atea Pharmaceuticals, Inc. Common Stock's Enterprise Value?

Atea Pharmaceuticals, Inc. Common Stock's Enterprise Value is $379.0M, based on as-reported figures from SEC (XBRL) filings.

What is Atea Pharmaceuticals, Inc. Common Stock's EV / EBITDA?

Atea Pharmaceuticals, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Atea Pharmaceuticals, Inc. Common Stock's Net Income (TTM)?

Atea Pharmaceuticals, Inc. Common Stock's Net Income (TTM) is -$165.3M, based on as-reported figures from SEC (XBRL) filings.

What is Atea Pharmaceuticals, Inc. Common Stock's EBITDA?

Atea Pharmaceuticals, Inc. Common Stock's EBITDA is -$183.2M, based on as-reported figures from SEC (XBRL) filings.

What is Atea Pharmaceuticals, Inc. Common Stock's Diluted EPS (TTM)?

Atea Pharmaceuticals, Inc. Common Stock's Diluted EPS (TTM) is -2.06, based on as-reported figures from SEC (XBRL) filings.

What is Atea Pharmaceuticals, Inc. Common Stock's Net Debt?

Atea Pharmaceuticals, Inc. Common Stock's Net Debt is -$76.5M, based on as-reported figures from SEC (XBRL) filings.

Atea Pharmaceuticals, Inc. Common Stock (AVIR) Financial Statements

Atea Pharmaceuticals, Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG00TZNCJ84

XNAS · usd

5.68▼ 0.15 (-2.57%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close5.83

Day's Range5.64 – 5.85

52-Week Range2.78 – 6.45

Volume216.0K

Avg Volume314.0K

Share Statistics

Shares Outstanding

Employees55

ExchangeXNAS

Listed2020-10-30

Share count as of August 10, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Atea Pharmaceuticals, Inc. Common Stock (AVIR)

What is Atea Pharmaceuticals, Inc. Common Stock's Market Cap?: Atea Pharmaceuticals, Inc. Common Stock's Market Cap is $455.6M, based on as-reported figures from SEC (XBRL) filings.
What is Atea Pharmaceuticals, Inc. Common Stock's Enterprise Value?: Atea Pharmaceuticals, Inc. Common Stock's Enterprise Value is $379.0M, based on as-reported figures from SEC (XBRL) filings.
What is Atea Pharmaceuticals, Inc. Common Stock's EV / EBITDA?: Atea Pharmaceuticals, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Atea Pharmaceuticals, Inc. Common Stock's Net Income (TTM)?: Atea Pharmaceuticals, Inc. Common Stock's Net Income (TTM) is -$165.3M, based on as-reported figures from SEC (XBRL) filings.
What is Atea Pharmaceuticals, Inc. Common Stock's EBITDA?: Atea Pharmaceuticals, Inc. Common Stock's EBITDA is -$183.2M, based on as-reported figures from SEC (XBRL) filings.
What is Atea Pharmaceuticals, Inc. Common Stock's Diluted EPS (TTM)?: Atea Pharmaceuticals, Inc. Common Stock's Diluted EPS (TTM) is -2.06, based on as-reported figures from SEC (XBRL) filings.
What is Atea Pharmaceuticals, Inc. Common Stock's Net Debt?: Atea Pharmaceuticals, Inc. Common Stock's Net Debt is -$76.5M, based on as-reported figures from SEC (XBRL) filings.